Nature Medicine · 2001 · 545 citations · 25 references
PharmacyImmunologyOncologyCancer ImmunologyMonoclonal AntibodiesTumor ImmunologyAntibody CharacterizationCancer ImmunotherapyMonoclonal Antibody TherapyTherapeutic Antibody DevelopmentTherapeutic Monoclonal AntibodiesMolecularly Targeted AgentsMonoclonal Antibodies In CancerMonoclonal Antibodies In OncologyMonoclonal Antibody Therapeutics
25
Identification and characterization of a new member of the TNF family that induces apoptosis
Steven R. Wiley, Ken Schooley, Pamela J. Smolak et al. · Immunity · 1995 · 2.9K citations · Full text
Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo
Henning Walczak, Robert E. Miller, K. Ariail et al. · Nature Medicine · 1999 · 2.5K citations
Safety and antitumor activity of recombinant soluble Apo2 ligand
Avi Ashkenazi, Roger Pai, Sharon Fong et al. · Journal of Clinical Investigation · 1999 · 2.2K citations · Full text
Medicine, Oncology, Pharmacology +17
The Receptor for the Cytotoxic Ligand TRAIL
Guohua Pan, Karen O’Rourke, Arul M. Chinnaiyan et al. · Science · 1997 · 1.8K citations
Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors
James P. Sheridan, Scot A. Marsters, Robert Pitti et al. · Science · 1997 · 1.7K citations